Table 3 |
||||||||||||||
|
Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), positive and negative likelihood ratios with 95% confidence intervals for screening at 32 weeks or 36 weeks, using low vaginal (LVS) and/or perianal (PAS) swabs for 600 women and for using a risk factor strategy*. |
||||||||||||||
|
32 Weeks (n = 600) |
36 Weeks (n = 600) |
(n= 699) |
||||||||||||
|
|
||||||||||||||
|
LVS |
PAS |
Either |
LVS |
PAS |
Either |
|||||||||
|
|
||||||||||||||
|
Estimate + 95% CI |
Estimate + 95% CI |
Estimate + 95% CI |
Estimate + 95% CI |
Estimate + 95% CI |
Estimate + 95% CI |
Estimate + 95% CI |
||||||||
|
|
||||||||||||||
|
Sensitivity |
63 |
54–71 |
70 |
61–77 |
72 |
63–79 |
73 |
65–81 |
76 |
67–83 |
81 |
73–87 |
19 |
13–26 |
|
Specificity |
94 |
92–96 |
94 |
91–96 |
93 |
90–95 |
95 |
93–97 |
94 |
91–96 |
93 |
90–95 |
83 |
79–86 |
|
PPV* |
77 |
68–84 |
76 |
68–84 |
75 |
66–82 |
82 |
74–88 |
78 |
70–85 |
77 |
69–84 |
25 |
18–34 |
|
NPV |
90 |
87–92 |
91 |
89–94 |
92 |
89–94 |
92 |
90–95 |
93 |
90–95 |
94 |
92–96 |
77 |
73–80 |
|
Likelihood ratio (+ve) |
11.3 |
7.6–16.7 |
11.2 |
7.7–16.2 |
10.1 |
7.2–14.3 |
15.5 |
10.2-23.6 |
12.1 |
8.4-17.5 |
11.7 |
8.3-16.6 |
1.10 |
0.76-1.59 |
|
Likelihood ratio (-ve) |
0.39 |
0.31–0.49 |
0.32 |
0.25–0.42 |
0.30 |
0.23–0.40 |
0.28 |
0.21–0.37 |
0.26 |
0.19–0.35 |
0.21 |
0.15–0.29 |
0.98 |
0.90–1.06 |
|
Diagnostic Odds Ratio |
28.7 |
16.4–50.6 |
34.5 |
19.8–60.4 |
33.4 |
19.4–57.9 |
55.4 |
30.1–103 |
46.5 |
26.1–83.1 |
56.7 |
31.4–103 |
1.12 |
0.69–1.79 |
|
|
||||||||||||||
|
* Risk factor strategy included women with GBS bacteruria at booking, birth at <37 weeks' gestation, prelabour rupture of membranes or temperature during labour of greater than or equal to 38 degrees Centrigrade. |
||||||||||||||
|
Hiller et al. BMC Pregnancy and Childbirth 2005 5:12 doi:10.1186/1471-2393-5-12 |
||||||||||||||